temoporfin has been researched along with Cancer of Head in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (5.41) | 18.2507 |
2000's | 15 (40.54) | 29.6817 |
2010's | 16 (43.24) | 24.3611 |
2020's | 4 (10.81) | 2.80 |
Authors | Studies |
---|---|
Calvaresi, M; Costantini, PE; Danielli, A; Di Giosia, M; Fimognari, C; Marconi, A; Marforio, TD; Mattioli, EJ; Pellicioni, V; Turrini, E; Ulfo, L | 1 |
Bezdetnaya, L; François, M; Lamy, L; Yakavets, I | 1 |
Bezdetnaya, L; Chateau, A; Dirheimer, L; Francois, A; Lassalle, HP; Yakavets, I | 1 |
Bezdetnaya, L; Francois, A; Gazeau, F; Lamy, L; Piffoux, M; Silva, AKA; Wilhelm, C; Yakavets, I; Zorin, V | 1 |
Choudhary, MG; Gadbail, AR; Gondivkar, SM; Likhitkar, MS; Vedpathak, PR | 1 |
Karakullukçu, MB; Lopez-Yurda, M; Schreuder, WH; Tan, IB; van Doeveren, TEM; van Veen, RLP | 1 |
Albrecht, V; Ashtikar, M; Gao, G; Jablonka, L; Jung, F; Preuß, A; Röder, B; Scheglmann, D; Thurn, M; Wacker, MG | 1 |
Bottini, G; Hopper, C; Lee, G; Story, W; Sultan, AA; Vaz, F | 1 |
Algharib, AM; Hopper, C; Parekh, J; Sultan, A; Vaz, F | 1 |
de Visscher, S; Helfrich, W; Peng, W; Roodenburg, JL; Samplonius, DF; Witjes, MJ | 1 |
Horlings, RK; Terra, JB; Witjes, MJ | 1 |
Bielawska, A; Bielawski, J; Boppana, NB; Delor, JS; Korbelik, M; Kraveka, JM; Li, LI; Pierce, JS; Rahmaniyan, M; Separovic, D; Zhang, K | 1 |
Albrecht, V; Betz, CS; Hopper, C; Nifantiev, NE; Rauschning, W; Riabov, MV; Stranadko, EP | 1 |
Carstens, MG; Flesch, FM; Helwig, C; Hennink, WE; Hofman, JW; van Nostrum, CF; van Zeeland, F | 1 |
Lorenz, KJ; Maier, H | 2 |
Akram, S; Hamdoon, Z; Hopper, C; Jerjes, W; Upile, T | 1 |
Ceruse, P; Dolivet, G; Rauschning, W; Roest, G; Tan, IB; Vander Poorten, V | 1 |
Bhatti, G; Bielawski, J; Korbelik, M; Merchant, S; Ogretmen, B; Pierce, JS; Separovic, D; Tarca, AL | 1 |
Akram, S; Hamdoon, Z; Hopper, C; Jerjes, W; Morley, S; Mosse, CA; Upile, T | 1 |
Korbelik, M; Separovic, D; Zhang, W | 2 |
Al-Delayme, R; Hamdoon, Z; Hopper, C; Jerjes, W | 1 |
de Visscher, SA; Dijkstra, PU; Roodenburg, JL; Tan, IB; Witjes, MJ | 1 |
Banerjee, AS; Benjamin, E; Dilkes, MG; Ovaisi, S | 1 |
Hopper, C; Niziol, C; Sidhu, M | 1 |
Biel, MA; D'Cruz, AK; Robinson, MH | 1 |
Bown, SG; Hopper, C; Jäger, HR; Jones, L; Lou, PJ; Theodossy, T | 1 |
Gerber-Leszczyszyn, H; Marszalik, P; Ziółkowski, P | 1 |
Baas, P; Out, R; Ruevekamp, M; Schellens, J; Stewart, FA; Triesscheijn, M; Van Berkel, TJ | 1 |
Naim, R | 1 |
DeJode, ML; Dilkes, MG; Gardiner, Q; Kenyon, GS; McKelvie, P | 1 |
Haase, T; Kahle, B; Kübler, AC; Mühling, J; Rheinwald, M; Staff, C | 1 |
Andrejevic Blant, S; Ballini, JP; Fontolliet, C; Grosjean, P; Monnier, P; van den Bergh, H; Wagnières, G | 1 |
Flechtenmacher, C; Kübler, AC; Reuther, T; Sinn, H; Zillmann, U | 1 |
Morris, K | 1 |
Oppelaar, H; Snow, GB; Stigter, M; van Dongen, GA; Visser, GW; Vrouenraets, MB | 1 |
5 review(s) available for temoporfin and Cancer of Head
Article | Year |
---|---|
Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: A systematic review.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Chlorophyllides; Databases, Factual; Dihematoporphyrin Ether; Erythroplasia; Head and Neck Neoplasms; Hematoporphyrins; Humans; Hyperplasia; Indoles; Laser Therapy; Lasers; Leukoplakia; Leukoplakia, Oral; Mesoporphyrins; Oral Submucous Fibrosis; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Porphyrins; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2018 |
mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2015 |
mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Mesoporphyrins; Neoplasm Staging; Palliative Care; Photochemotherapy; Photosensitizing Agents; Quality of Life; Remission Induction | 2013 |
Photodynamic therapy of head and neck tumors and non-tumor like disorders.
Topics: Clinical Trials as Topic; Dihematoporphyrin Ether; Head and Neck Neoplasms; Hematoporphyrin Photoradiation; Humans; Indoles; Isoindoles; Light; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Porphobilinogen Synthase; Treatment Outcome | 2004 |
[Photodynamic therapy using m-THPC (Foscan). Treatment of head and neck squamous cell carcinoma].
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Clinical Trials as Topic; Head and Neck Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Treatment Outcome | 2008 |
7 trial(s) available for temoporfin and Cancer of Head
Article | Year |
---|---|
Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2008 |
Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents | 2010 |
Interstitial PDT for vascular anomalies.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Head and Neck Neoplasms; Hemangioma; Humans; Infant; Lymphatic Abnormalities; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome; Vascular Malformations; Young Adult | 2011 |
Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Palliative Care; Photochemotherapy; Photosensitizing Agents; Salvage Therapy; Treatment Outcome | 2004 |
The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
Topics: Animals; Antineoplastic Agents; Apolipoproteins E; Area Under Curve; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Half-Life; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Mesoporphyrins; Mice; Mice, Inbred BALB C; Mice, Knockout; Neoplasms; Photochemotherapy; Photosensitizing Agents; Scavenger Receptors, Class B; Species Specificity; Tissue Distribution | 2007 |
[Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2008 |
Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck.
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Laser Therapy; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prognosis; Prospective Studies; Radiation Dosage; Skin Neoplasms; Survival Rate; Treatment Outcome | 1999 |
25 other study(ies) available for temoporfin and Cancer of Head
Article | Year |
---|---|
Carrying Temoporfin with Human Serum Albumin: A New Perspective for Photodynamic Application in Head and Neck Cancer.
Topics: Head and Neck Neoplasms; Humans; Photochemotherapy; Reactive Oxygen Species; Serum Albumin, Human; Squamous Cell Carcinoma of Head and Neck | 2022 |
Phototoxicity of temoporfin-loaded cyclodextrin nanosponges in stroma-rich three-dimensional models of head and neck cancer.
Topics: Head and Neck Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Polymers | 2023 |
A Macrophages-Enriched Head and Neck Tumor Spheroid Model to Study Foslip
Topics: Cell Line, Tumor; Culture Media, Conditioned; Head and Neck Neoplasms; Humans; Macrophages; Squamous Cell Carcinoma of Head and Neck; Tumor Microenvironment | 2023 |
Effect of stroma on the behavior of temoporfin-loaded lipid nanovesicles inside the stroma-rich head and neck carcinoma spheroids.
Topics: Carcinoma; Coculture Techniques; Extracellular Matrix; Extracellular Vesicles; Head and Neck Neoplasms; HT29 Cells; Humans; Lipid Metabolism; Lipids; Liposomes; Mesoporphyrins; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Spheroids, Cellular; Tumor Microenvironment | 2021 |
Adjuvant photodynamic therapy in head and neck cancer after tumor-positive resection margins.
Topics: Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Male; Margins of Excision; Mesoporphyrins; Middle Aged; Netherlands; Photochemotherapy; Radiation-Sensitizing Agents; Retrospective Studies; Survival Rate; Treatment Outcome | 2018 |
Advanced in silico modeling explains pharmacokinetics and biodistribution of temoporfin nanocrystals in humans.
Topics: Antineoplastic Agents; Computer Simulation; Delayed-Action Preparations; Drug Liberation; Ethanol; Head and Neck Neoplasms; Humans; Mesoporphyrins; Nanoparticles; Particle Size; Propylene Glycol; Squamous Cell Carcinoma of Head and Neck; Tissue Distribution | 2019 |
Strategies of airway management for head and neck photo-dynamic therapy.
Topics: Airway Management; Airway Obstruction; Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Cricoid Cartilage; Dexamethasone; Female; Head and Neck Neoplasms; Humans; Intubation, Intratracheal; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Thyroid Cartilage; Tongue Neoplasms; Tracheostomy; Treatment Outcome | 2013 |
Endoluminal tracheal stenting prior to head and neck PDT.
Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Squamous Cell Carcinoma of Head and Neck; Stents; Tracheal Stenosis; Treatment Outcome | 2014 |
Photochemical internalization (PCI)-mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells.
Topics: Antineoplastic Agents; Bleomycin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Liposomes; Mesoporphyrins; Microscopy, Fluorescence; Photochemotherapy; Photosensitizing Agents; Spectrometry, Fluorescence; Tumor Cells, Cultured | 2014 |
Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide.
Topics: Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Ceramides; Combined Modality Therapy; Endoplasmic Reticulum Stress; Fenretinide; Fumonisins; Head and Neck Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Pyridinium Compounds; Radiation-Sensitizing Agents; Squamous Cell Carcinoma of Head and Neck | 2017 |
Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation.
Topics: Caproates; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Lactones; Lipase; Liposomes; Mesoporphyrins; Micelles; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Technology, Pharmaceutical | 2008 |
Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Follow-Up Studies; Germany; Head and Neck Neoplasms; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Cystic hygroma treated with ultrasound guided interstitial photodynamic therapy: case study.
Topics: Head and Neck Neoplasms; Humans; Infant; Lymphangioma, Cystic; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Ultrasonography | 2010 |
Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.
Topics: Animals; Biomarkers; Carcinoma, Squamous Cell; Ceramides; Disease Models, Animal; Female; Head and Neck Neoplasms; Mesoporphyrins; Mice; Mice, Inbred C3H; Photochemotherapy; Photosensitizing Agents; Pyridinium Compounds; Spectrometry, Mass, Electrospray Ionization; Sphingolipids; Treatment Outcome | 2011 |
Amplification of cancer cell apoptosis in photodynamic therapy-treated tumors by adjuvant ceramide analog LCL29.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium; Carcinoma, Squamous Cell; Ceramides; Chemotherapy, Adjuvant; Flow Cytometry; Head and Neck Neoplasms; Macrophages; Mesoporphyrins; Mice; Mice, Inbred C3H; Mitochondria; Phagocytosis; Photochemotherapy; Photosensitizing Agents; Pyridinium Compounds | 2011 |
Monitoring ceramide and sphingosine-1-phosphate levels in cancer cells and macrophages from tumours treated by photodynamic therapy.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Ceramides; Head and Neck Neoplasms; Indoles; Lysophospholipids; Macrophages; Mesoporphyrins; Mice; Mice, Inbred C3H; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents; Pyridinium Compounds; Sphingosine | 2012 |
Solitary giant neurofibroma of the neck subjected to photodynamic therapy: case study.
Topics: Aged; Female; Head and Neck Neoplasms; Humans; Mesoporphyrins; Neurofibroma; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2012 |
Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Mesoporphyrins; Mouth Neoplasms; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Treatment Outcome | 2003 |
The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK.
Topics: Computer Simulation; Cost-Benefit Analysis; Head and Neck Neoplasms; Health Care Costs; Humans; Mesoporphyrins; Models, Econometric; Palliative Care; Photochemotherapy; Sensitivity and Specificity; Treatment Outcome; United Kingdom | 2004 |
mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Injections, Intravenous; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Quality of Life; Treatment Outcome | 2004 |
Treatment of head and neck cancer with photodynamic therapy: results after one year.
Topics: Aminolevulinic Acid; Antineoplastic Agents; Head and Neck Neoplasms; Hematoporphyrin Derivative; Humans; Mesoporphyrins; Photochemotherapy; Radiation-Sensitizing Agents; Treatment Outcome | 1995 |
Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study.
Topics: Aged; Bronchi; Carcinoma, Squamous Cell; Esophagus; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Microscopy, Fluorescence; Middle Aged; Mouth Mucosa; Photochemotherapy; Photosensitizing Agents; Time Factors | 2001 |
Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Dihematoporphyrin Ether; Disease Models, Animal; Excipients; Female; Head and Neck Neoplasms; Humans; Mesoporphyrins; Mice; Middle Aged; Photochemotherapy; Polyethylene Glycols; Radiation-Sensitizing Agents; Random Allocation; Transplantation, Heterologous; Treatment Outcome; Tumor Cells, Cultured | 2001 |
Ray of light for treatment of head and neck cancer.
Topics: Antineoplastic Agents; Head and Neck Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents | 2000 |
Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro.
Topics: Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Division; Head and Neck Neoplasms; Humans; Immunoconjugates; Indoles; Mesoporphyrins; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured | 2002 |